Ken Griffin West Pharmaceutical Services Inc Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 88,400 shares of WST stock, worth $18.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
88,400
Previous 42,200
109.48%
Holding current value
$18.7 Million
Previous $13.8 Million
43.17%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding WST
# of Institutions
803Shares Held
66.2MCall Options Held
415KPut Options Held
275K-
Vanguard Group Inc Valley Forge, PA9.23MShares$1.95 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY7.58MShares$1.6 Billion0.06% of portfolio
-
Brown Advisory Inc3.27MShares$690 Million1.1% of portfolio
-
State Street Corp Boston, MA3.2MShares$676 Million0.03% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.2MShares$463 Million0.85% of portfolio
About WEST PHARMACEUTICAL SERVICES INC
- Ticker WST
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,033,000
- Market Cap $15.6B
- Description
- West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...